A senior judge in Uruguay has ordered the government and Pfizer to provide “extensive detail” on the biochemical composition and evidence of efficacy and safety of its COVID vaccine within 48 hours.
All parties are scheduled to appear next Wednesday to find out if the vaccines contain “nanotechnological elements” among other things.
The Administrative Litigation Judge Alejandro Recarey ordered the Presidency of the Republic of Uruguay, the Ministry of Public Health (MSP), the State Health Services Administration (ASSE) and the multinational company Pfizer to present all the information regarding Covid-19 vaccines within 48 hours.
This notice was given in a case that began with the aim of suspending the application of these vaccines for children.
On Wednesday, a hearing is scheduled to be held at 9 in the morning where the representatives of all the aforementioned organizations and the company must appear, according to the TV Ciudad news program.
Among the aspects highlighted by the judge, are the contracts for the purchase of the vaccines, and if they contain clauses of civil indemnity or criminal impunity of the suppliers in the event of possible adverse effects.
They are also requested to provide “extensive detail” regarding the biochemical composition of the vaccines, how the batches were distributed, which ones contain messenger RNA and what meaning it has.
In addition, Judge Recarey wants to know about the possible “presence of graphene oxide” or “nanotechnological elements”, if the vaccines are “experimental or not” and information about “what is scientifically known about the effectiveness of those labeled as vaccines”, according to the daily El Observador.
Likewise, official figures are requested that “demonstrate the negative or positive incidence of the so-called vaccination in the number of infections and deaths with a diagnosis of Covid from the beginning of the campaign to date” and whether studies have been carried out “tending to explain the notorious increase in deaths from Covid-19 as of March 2021 in relation to the previous year”.
The judge also requested, in detail, the global average age of those who died with a diagnosis of Covid-19 and of these, how many were due to this disease.
